More Articles


Focus on the Patient and Everyone Wins

Hugh Gosling, (Apr 12, 2017)

Pharma is fluent in the language of patient-centricity but through its Patients First commitment, Pfizer seeks to embed the concept in its operational model

Janssen Named Most Admired Company

Danielle Barron, (Apr 10, 2017)

Janssen wins admiration of patients, doctors and peers in eyeforpharma awards 2017

Strictly Pushing Limits

Deirdre Coleman, (Apr 6, 2017)

TV dancing star and MS ambassador, Trishna Bharadia talks about transforming trials, championing caregivers and managing expectations

Born to Transform

Deirdre Coleman, (Apr 3, 2017)

Marc Princen is invigorated by what he does best – building and transforming businesses

Communicate Your Way to a Better Patient Experience

Deirdre Coleman, (Mar 31, 2017)

Making patients feel part of the team during a clinical trial can transform the trial experience for the better

Active Partners in Research

Deirdre Coleman, (Mar 29, 2017)

GSK are tapping into their consumer division's skill of capturing consumer insights - could FMCI (Fast-Moving Consumer Insights) be the way forward?

The Missing Link to Real-World Innovation

Jack Fitzgerald, (Mar 28, 2017)

The pharma industry loves digital pilots but struggles to translate them into live services

Tackling a Decade of Change

Hugh Gosling, (Mar 23, 2017)

Pharma must offer genuine solutions if it is to survive the challenges ahead, says Alistair Grenfell from QuintilesIMS

Shire: Standing Up For Patients

Hugh Gosling, (Mar 20, 2017)

Pharma companies must champion their patients to ensure their voices are heard, says Shire’s Perry Sternberg
Market Access

Arbiter of Value

Deirdre Coleman, (Mar 17, 2017)

ICER has the laudable mission of being an independent, trusted source of value assessment for medicines. We spoke to Chief Scientific Officer, Dan Ollendorf, about controversy, criticism and the power of collaboration.